The world has now confirmed over ten million cases of COVID-19 and the global pandemic rages on.
More than 500-thousand people have died of COVID-19, according to the World Health Organisation.
The virus seems to be an unstoppable force, and perhaps stronger than before, resurfacing in what some have called a second wave in South Korea, China, and other parts of the world that hoped they had flattened the curve.
Some countries like the UK expect the fallout to drag into next year.
To break down the situation and also learn about the drugs being developed to fight COVID-19, we connect with Dr. Eric Ding, health economist and a Visiting Scientist at the Harvard Chan School of Public Health.
In countries like South Korea and China, some say we're now experiencing a second wave of COVID-19 infections. What makes it a second wave, rather than just a continuation of the first wave?
What are the risks involved in a second wave and why do experts say it would likely be deadlier than the first?
Recent remarks by President Trump - that he claims to have made in jest have nevertheless raised eyebrows. What would happen if you actually slowed testing of COVID-19?
How should world leaders be responding to this public health crisis?
In the U.S., imposing lockdowns or even requiring the wearing of face masks has met a lot of resistance, and it looks like the White House won't be pushing for such measures anyway.
Should the individual be trusted to take socially responsible actions though?
British scientists found Dexamethasone can reduce mortality in COVID-19 patients on ventilation. Does this mean a significant number of deaths can be prevented now?
A few hours ago, we heard bio company Gilead Sciences is planning to charge more than 3-thousand dollars for its antiviral treatment for COVID-19. Is this a fair price for the drug? Could it set a dangerous precedent for other drugs hitting the market?
In terms of developing vaccines, some studies say they may only be effective for two to three months why is this the case?
Some countries are expecting the current level of daily infections and deaths to continue for months to come even until next year in the UK's case. Is there anything that can be done, or any hope of the situation improving?
What can members of the public do to suffer less from the 2nd wave?
That's where we'll have to wrap up our interview today. Dr. Eric Ding, a Visiting Scientist at the Harvard Chan School of Public Health. Thank you for joining the program.